Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections

NCT05799716 is registered in ClinicalTrials.gov with Shanghai Changzheng Hospital as lead sponsor.

NCT NCT05799716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05799716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections
Lead sponsor
Shanghai Changzheng Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
April 1, 2023
Completion date
September 1, 2024
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute rejection of renal transplant, bacteremia, viremia